Literature DB >> 31506155

[Effect of low-concentration paclitaxel on collagen deposition outside rat pulmonary artery smooth muscle cells and related mechanism].

Yan Luo1, Liang Xie, Han-Min Liu, Bin Liu.   

Abstract

OBJECTIVE: To study the effect of low-concentration paclitaxel (PTX) on transforming growth factor-β1 (TGF-β1)-induced collagen deposition outside rat pulmonary artery smooth muscle cells (PASMCs) and related mechanism.
METHODS: Primary rat PASMCs were divided into a blank control group (n=3), a model group (n=3), and a drug intervention group (n=3). No treatment was given for the blank control group. The model group was treated with TGF-β1 with a final concentration of 10 ng/mL. The drug intervention group was treated with PTX with a final concentration of 100 nmol/L in addition to the treatment in the model group. MTT colorimetry was used to measure cell proliferation. Quantitative real-time PCR was used to measure the relative mRNA expression of collagen type I (COL-I) and collagen type III (COL-III). ELISA was used to measure the OD value of COL-I and COL-III proteins. Western blot was used to measure the relative protein expression of COL-I, COL-III, and the key proteins of the TGF-β1/Smad3 signaling pathway (Smad3 and p-Smad3).
RESULTS: Compared with the blank control group, the model group had significant increases in proliferation ability, relative mRNA and protein expression of COL-I and COL-III, and relative protein expression of p-Smad3 (P<0.05). Compared with the model group, the drug intervention group had significant reductions in the above indicators, but which were still higher than those in the blank control group (P<0.05). There was no significant difference in the relative protein expression of Smad3 among the three groups (P>0.05).
CONCLUSIONS: Low-concentration PTX exerts a marked inhibitory effect on TGF-β1-induced collagen deposition outside PASMCs, possibly by regulating the phosphorylation of Smad3 protein.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31506155      PMCID: PMC7390237     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  13 in total

Review 1.  Paclitaxel: What has been done and the challenges remain ahead.

Authors:  Ezequiel Bernabeu; Maximiliano Cagel; Eduardo Lagomarsino; Marcela Moretton; Diego A Chiappetta
Journal:  Int J Pharm       Date:  2017-05-10       Impact factor: 5.875

2.  cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells.

Authors:  Kaizheng Gong; Dongqi Xing; Peng Li; Robert H Hilgers; Fadi G Hage; Suzanne Oparil; Yiu-Fai Chen
Journal:  Mol Endocrinol       Date:  2011-08-25

3.  Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity.

Authors:  Dongshan Zhang; Lin Sun; Wang Xian; Fuyou Liu; Guanghui Ling; Li Xiao; Yanhong Liu; Youmin Peng; Yoshisuke Haruna; Yashpal S Kanwar
Journal:  Lab Invest       Date:  2010-02-08       Impact factor: 5.662

4.  Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity.

Authors:  Jun Zhou; De-Wu Zhong; Qun-Wei Wang; Xiong-Ying Miao; Xun-Di Xu
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

5.  Microtubule binding to Smads may regulate TGF beta activity.

Authors:  C Dong; Z Li; R Alvarez; X H Feng; P J Goldschmidt-Clermont
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

6.  [Adrenomedullin inhibits TGF-β1-induced procollagen expression in cultured human fetal lung fibroblasts via Smad2/3 pathway].

Authors:  Shuling Hao; Weiping Wang; Zhonghe Yu; Jiandong Li
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2014-11

Review 7.  Myofibroblasts and lung fibrosis induced by carbon nanotube exposure.

Authors:  Jie Dong; Qiang Ma
Journal:  Part Fibre Toxicol       Date:  2016-11-04       Impact factor: 9.400

8.  Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway.

Authors:  Jingyu Ni; Yang Shi; Lan Li; Jingrui Chen; Lingyan Li; Min Li; Jinqiang Zhu; Yan Zhu; Guanwei Fan
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-15       Impact factor: 2.629

Review 9.  Paclitaxel: new uses for an old drug.

Authors:  Dongshan Zhang; Ruhao Yang; Shixuan Wang; Zheng Dong
Journal:  Drug Des Devel Ther       Date:  2014-02-20       Impact factor: 4.162

10.  In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons.

Authors:  Emily Turner; Megan Erwin; Marzieh Atigh; Uwe Christians; Justin M Saul; Saami K Yazdani
Journal:  Front Pharmacol       Date:  2018-07-30       Impact factor: 5.810

View more
  1 in total

1.  Wasting condition as a marker for severe disease in pediatric Crohn's disease.

Authors:  Wook Jin; Dong-Hwa Yang; Hann Tchah; Kwang-An Kwon; Jung-Ho Kim; Su-Jin Jeong; Ki-Baik Hahm
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.